Weight Loss and Abdominal Pain in Diabetic Man: What Test?

News
Article

What study would you order to determine the cause of progressively worsening crampy abdominal pain and unintentional weight loss in an older patient with diabetes?

A 74-year-old man with diabetes presents with a chief complaint of crampy abdominal pain, particularly following meals, that has been progressively worsening over the past 6 months. Since that time, he has unintentionally lost 8 lb. His stools have been loose, but otherwise unremarkable. Which of the following studies would reveal the most likely diagnosis?

A. Esophagogastroduodenoscopy
B. RUQ ultrasonogram
C Colonoscopy                                 
D. CT angiography of the abdomen

 

 Please click here for the answer and discussion.

Recent Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
Related Content
Real-World Data Highlight Impact of Treatment Discontinuation on Obesity Pharmacotherapy Outcomes

Real-World Data Highlight Impact of Treatment Discontinuation on Obesity Pharmacotherapy Outcomes

Sydney Jennings
July 10th 2025
Article

A recent study highlights the importance of medication adherence for significant weight loss and improved glycemic control in obesity treatment with GLP-1 agonists.

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

Sydney Jennings
August 30th 2023
Podcast

Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.

BF% outperforms BMI in Predicting Morality risk in young adults: New Findings / image courtesy of University of Florida

Body Fat Percentage Outperforms BMI in Predicting Mortality Risk in Young Adults: New Findings

Grace Halsey
July 8th 2025
Article

Body fat percentage and waist circumference were both significantly associated with 15-year all-cause mortality while BMI had no significant association.

Obesity & Type 2 Diabetes: An Expert Discussion

Obesity & Type 2 Diabetes: An Expert Discussion

Sydney Jennings
June 30th 2023
Podcast

In our latest episode, 2 obesity experts discuss the importance of early intervention to reduce risk for complications, suggestions for managing patients in primary care, and more.

Once-Monthly Maridebart Cafraglutide Produces Up to 20% Weight Loss in Phase 2 Trial

Once-Monthly Maridebart Cafraglutide Produces Up to 20% Weight Loss in Phase 2 Trial

Sydney Jennings
June 26th 2025
Article

ADA 2025: Once-monthly dosing led to significant weight loss in adults with obesity, with or without type 2 diabetes, reported researchers.

Viking Advances GLP-1/GIP Agonist VK2735 into Late Stage Clinical Program for Obesity / image credit ©Viking Therapeutics

Viking Advances GLP-1/GIP Agonist VK2735 into Late Stage Clinical Program for Obesity

Grace Halsey
June 26th 2025
Article

Viking Therapeutics initiates phase 3 trials for VK2735, a promising dual incretin agonist targeting obesity and other metabolic disorders, based on strong phase 2 findings.

© 2025 MJH Life Sciences

All rights reserved.